Novavax Inc. Stock Slides 3.7%, Underperforms Peers
Dow Jones2026/10/21 20:35This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Novavax Inc. slid 3.7% to $11.01 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 1.1% to 26,702.86 and the Dow Jones Industrial Average rising 0.7% to 52,856.09.
Novavax Inc. closed 17.7% below its 52-week high of $13.39, which the company reached on October 5th.
The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 0.6% to $257.78, Pfizer Inc. fell 0.9% to $29.85, and Merck & Co. Inc. rose 1.07% to $149.88.
Trading volume totaled 5.4 million, compared to the 50-day average of 6.7 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 21, 2026 16:35 ET (20:35 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Enterprises had a net reduction of 11,647 BTC last week, worth approximately $869 million.
Capstone Holding Extends Debt Maturity Under Agreement With 3i
Crypto prices
More
